References
Hao S, Fan P, Chen S, Tu C, Wan C. Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2017;21(2):312–20. https://doi.org/10.1007/s11605-016-3311-z.
Li Q, Wang J, Juzi JT, Sun Y, Zheng H, Cui Y et al. Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2008;12(9):1540–7. https://doi.org/10.1007/s11605-008-0591-y.
Wang B, Xia CY, Lau WY, Lu XY, Dong H, Yu WL et al. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery. Journal of the American College of Surgeons. 2013;217(6):1054–62. https://doi.org/10.1016/j.jamcollsurg.2013.07.402.
Matsuda M, Fujii H, Kono H, Matsumoto Y. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. Journal of hepato-biliary-pancreatic surgery. 2001;8(4):353–9. https://doi.org/10.1007/s0053410080353.
Zhang X, Li C, Wen T, Yan L, Li B, Yang J et al. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern. European journal of gastroenterology & hepatology. 2015;27(8):933–40. https://doi.org/10.1097/MEG.0000000000000383.
Hu Z, Wang W, Li Z, Ye S, Zheng SS. Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2012;18(11):1316–23. https://doi.org/10.1002/lt.23521.
Ferrer-Fabrega J, Forner A, Liccioni A, Miquel R, Molina V, Navasa M et al. Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection. Hepatology. 2016;63(3):839–49.
Sala M, Fuster J, Llovet JM, Navasa M, Sole M, Varela M et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2004;10(10):1294–300. https://doi.org/10.1002/lt.20202.
Hu Z, Zhou J, Li Z, Xiang J, Qian Z, Wu J et al. Time interval to recurrence as a predictor of overall survival in salvage liver transplantation for patients with hepatocellular carcinoma associated with hepatitis B virus. Surgery. 2015;157(2):239–48. https://doi.org/10.1016/j.surg.2014.09.018.
Author information
Authors and Affiliations
Contributions
Zhang XY and Li C discussed and drafted the manuscript. Wen TF performed critical review and final approval of the article.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Zhang, X., Li, C. & Wen, T. Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma: What Is More Is About Different Therapeutic Strategies. J Gastrointest Surg 21, 2148–2149 (2017). https://doi.org/10.1007/s11605-017-3553-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-017-3553-4